GUD things are Afoot!Roughly, JRG in two days, adds almost $400k, give or take..
The newly minted CEO is in for almost an additional $40,000.
Agian, not the kind of action any Captial Allocator/Pharma investors would make unless they see grand opportuntities before them.
Do you think they have anything to base these investment decision upon?
Have they had any significant experience to go by?
Even as the broader market is elevated, prudent Investment analysis takes hold.
The probabilities of success must greatly outweigh the risks, if any.
GI